Surgical oncology during the post-COVID-19 era: What is next?
- PMID: 36129404
- DOI: 10.1002/jso.27104
Surgical oncology during the post-COVID-19 era: What is next?
Abstract
During first outburst of COVID-19, several strategies had been applied for surgical oncology patients to minimize COVID-19 transmission. COVID-19 infection seemed to compromise survival and major complication rates of surgical oncology patients. However, survival, tumor progression and recurrence rates of surgical oncology patients were associated to the consequences of COVID-19 pandemic on their management. In addition, the severity of COVID-19 infections has been downgraded. Therefore, management of surgical oncology patients should be reconsidered.
Keywords: COVID-19; cancer; multidisciplinary; surgical; treatment.
© 2022 Wiley Periodicals LLC.
References
REFERENCES
-
- World Health Organization, Coronavirus disease (COVID-19), 12 October 2020. 2020.
-
- Moris D, &Schizas D. Lockdown during COVID-19: the Greek success. In Vivo. 2020;34(3 suppl):1695-1699.
-
- Frountzas M, Schizas D, Kykalos S, Karydakis L, Terra A, G Toutouzas K. What did the surgical community learn from COVID-19 lockdown. Balkan Med J. 2021;38(4):255-256.
-
- Alexiou GA, Lianos GD, Alexiou ES, Voulgaris S. Biomarkers to safely discharge head trauma patients in the COVID-19 pandemic era. Future Medicine. 2021;15:319-321.
-
- Moris D, Tsilimigras DI, Schizas D. Cancer and COVID-19. Lancet. 2020;396(10257):1066.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
